<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>DOXY 100- doxycycline hyclateÂ injection, powder, lyophilized, for solutionÂ </strong><br>Fresenius Kabi USA, LLC<br></p></div>
<h1>Doxycycline for Injection USP</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="a26fdad6-f1e0-44f4-8752-85cb1d04d2f2"></a><a name="section-1"></a><p></p>
<h1></h1>
<span class="Italics"><span class="Emphasis">FOR IV INFUSION ONLY</span></span><p class="First">To reduce the development of drug-resistant bacteria and maintain the effectiveness of Doxycycline for Injection, USP and other antibacterial drugs, Doxycycline for Injection, USP should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by bacteria. <span class="Italics"><span class="Emphasis"><br></span></span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="ac2a8b82-9010-419e-922e-2faf43d00517"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Doxycycline for Injection, USP is a sterile, lyophilized powder prepared from a solution of doxycycline hyclate, ascorbic acid and mannitol in Water for Injection.Â  Doxycycline hyclate is a broad spectrum antibiotic derived from oxytetracycline.Â  It is meant for INTRAVENOUS use only after reconstitution.Â  Doxycycline hyclate is a yellowish crystalline powder which is chemically designated 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-de monohydrochloride, compound with ethyl alcohol (2:1), monohydrate. It has the following structural formula: </p>
<p><img alt="structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b0894010-39bd-459f-8563-cf83343105ee&amp;name=doxycycline-for-injection-usp-figure-1-doxy-struc.jpg">Â </p>
<p>Doxycycline hyclate is soluble in water and chars at 201Â°C without melting.Â  The base doxycycline has a high degree of lipid solubility and a low affinity for calcium binding.Â  It is highly stable in normal human serum.</p>
<p>Each 100 mg vial contains: Doxycycline hyclate equivalent to 100 mg doxycycline; ascorbic acid 480 mg; mannitol 300 mg.Â  pH of the reconstituted solution (10 mg/mL) is between 1.8 and 3.3.</p>
<p>Each 200 mg vial contains: Doxycycline hyclate equivalent to doxycycline 200 mg; ascorbic acid 960 mg; mannitol 600 mg.Â  pH of the reconstituted solution (10 mg/mL) is between 1.8 and 3.3.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="c32b1dad-6008-4066-91ba-f32b99406a42"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Tetracyclines are readily absorbed and are bound to plasma proteins in varying degree.Â  They are concentrated by the liver in the bile, and excreted in the urine and feces at high concentrations and in a biologically active form.</p>
<p>Following a single 100 mg dose administered in a concentration of 0.4 mg/mL in a one-hour infusion, normal adult volunteers averaged a peak of 2.5 mcg/mL, while 200 mg of a concentration of 0.4 mg/mL administered over two hours averaged a peak of 3.6 mcg/mL.</p>
<p>Excretion of doxycycline by the kidney is about 40 percent/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).Â  This percentage of excretion may <span class="product-label-link" type="condition" conceptid="436583" conceptname="Fall">fall</span> as low as 1 to 5 percent/72 hours in individuals with severe <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span> (creatinine clearance below 10 mL/min).Â  Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>.</p>
<p>Hemodialysis does not alter this serum half-life of doxycycline.</p>
<p><span class="Italics"><span class="Emphasis"><span class="Bold">Microbiology</span></span></span></p>
<p><span class="Bold"><span class="Emphasis">Mechanism of Action</span></span></p>
<p>Doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.Â  Doxycycline has bacteriostatic activity against a broad range of Gram-positive and Gram-negative bacteria.Â  Cross resistance with other tetracyclines is common.</p>
<p>Doxycycline has been shown to be active against most isolates of the following bacteria, both <span class="Italics"><span class="Emphasis">in vitro </span></span>and in clinical <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> (see <span class="Bold"><span class="Emphasis">INDICATIONS AND USAGE</span></span>).</p>
<p><span class="Bold"><span class="Emphasis">Gram-Negative Bacteria</span></span></p>
<p><span class="Italics"><span class="Emphasis">Acinetobacter </span></span>species</p>
<p><span class="Italics"><span class="Emphasis">Bartonella bacilliformis</span></span></p>
<p><span class="Italics"><span class="Emphasis">Brucella </span></span>species</p>
<p><span class="Italics"><span class="Emphasis">Cal</span></span><span class="Italics"><span class="Emphasis">ymmatobacterium</span></span>Â <span class="Italics"><span class="Emphasis">granulomatis</span></span></p>
<p><span class="Italics"><span class="Emphasis">Campylobacter fetus</span></span></p>
<p><span class="Italics"><span class="Emphasis">Enterobacter aerogenes</span></span></p>
<p><span class="Italics"><span class="Emphasis">Escherichia coli</span></span></p>
<p><span class="Italics"><span class="Emphasis">Francisella tularensis</span></span></p>
<p><span class="Italics"><span class="Emphasis">Haemophilus ducreyi</span></span></p>
<p><span class="Italics"><span class="Emphasis">Haemophilus influenzae</span></span></p>
<p><span class="Italics"><span class="Emphasis">Klebsiella </span></span>species</p>
<p><span class="Italics"><span class="Emphasis">Neisseria gonorrhoeae</span></span></p>
<p><span class="Italics"><span class="Emphasis">Shigella </span></span>species</p>
<p><span class="Italics"><span class="Emphasis">Vibrio cholerae</span></span></p>
<p><span class="Italics"><span class="Emphasis">Yersinia pestis</span></span>Â </p>
<p><span class="Bold"><span class="Emphasis">Gram-Positive Bacteria</span></span></p>
<p><span class="Italics"><span class="Emphasis">Bacillus anthracis</span></span></p>
<p><span class="Italics"><span class="Emphasis">Streptococcus pneumoniae</span></span>Â </p>
<p><span class="Bold"><span class="Emphasis">Anaerobes</span></span></p>
<p><span class="Italics"><span class="Emphasis">Clostridium </span></span>species</p>
<p><span class="Italics"><span class="Emphasis">Fusobacterium fusiforme</span></span></p>
<p><span class="Italics"><span class="Emphasis">Propionibacterium <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acnes</span></span></span>Â </p>
<p><span class="Bold"><span class="Emphasis">Other Bacteria</span></span></p>
<p><span class="Italics"><span class="Emphasis">Actinomyces </span></span>species</p>
<p><span class="Italics"><span class="Emphasis">Borrelia recurrentis</span></span></p>
<p><span class="Italics"><span class="Emphasis">Chlamydophila psittaci</span></span></p>
<p><span class="Italics"><span class="Emphasis">Chlamydia trachomatis</span></span></p>
<p><span class="Italics"><span class="Emphasis">Mycoplasma pneumoniae</span></span></p>
<p>Rickettsiae</p>
<p><span class="Italics"><span class="Emphasis">Treponema pallidum</span></span></p>
<p><span class="Italics"><span class="Emphasis">Treponema pertenue</span></span></p>
<p><span class="Italics"><span class="Emphasis">Ureaplasma urealyticum <br></span></span></p>
<p><span class="Bold"><span class="Emphasis">Parasites</span></span></p>
<p><span class="Italics"><span class="Emphasis">Balantidium coli</span></span></p>
<p><span class="Italics"><span class="Emphasis">Entamoeba </span></span>species</p>
<p><span class="Italics"><span class="Emphasis">Plasmodium falciparum</span></span>*</p>
<p>*Doxycycline has been found to be active against the asexual erythrocytic forms of <span class="Italics"><span class="Emphasis">Plasmodium falciparum </span></span>but not against the gametocytes of <span class="Italics"><span class="Emphasis">P. falciparum.</span></span>Â  The precise mechanism of action of the drug is not known.</p>
<p><span class="Bold"><span class="Emphasis"><span class="Italics">Susceptibility Test Methods</span></span></span></p>
<p>When available, the clinical microbiology laboratory should provide the results of <span class="Italics"><span class="Emphasis">in vitro </span></span>susceptibility test results for antimicrobial drugs used in resident hospitals to the physician as periodic reports that describe the susceptibility profile of nosocomial and community-acquired pathogens. Â These reports should aid the physician in selecting the most effective antimicrobial. </p>
<p><span class="Bold"><span class="Emphasis">Dilution Techniques</span></span></p>
<p>Quantitative methods are used to determine antimicrobial <span class="product-label-link" type="condition" conceptid="4190299" conceptname="Broth microdilution susceptibility test">minimum inhibitory concentrations</span> (MICs).Â  These MICs provide estimates of the susceptibility of bacteria to antimicrobial compounds. Â The MICs should be determined using a standardized test method (broth and/or agar).<span class="Sup">1,2,4</span>Â  The MIC values should be interpreted according to the criteria provided in Table 1.<span class="Bold"><span class="Emphasis">Â <br></span></span></p>
<p><span class="Bold"><span class="Emphasis">Diffusion Techniques</span></span></p>
<p>Quantitative methods that require measurement of zone diameters can also provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. Â Zone size provides an estimate of the susceptibility of bacteria to antimicrobial compounds. Â The zone size should be determined using a standard test method.<span class="Sup">1,3,4</span>Â  This procedure uses paper disks impregnated with 30 mcg doxycycline to test the susceptibility of bacteria to doxycycline. Â The disk diffusion interpretive criteria are provided in Table 1.<span class="Bold"><span class="Emphasis">Â <br></span></span></p>
<p><span class="Bold"><span class="Emphasis">Anaerobic Techniques</span></span></p>
<p>For anaerobic bacteria, the susceptibility to doxycycline can be determined by a standardized test method<span class="Sup">5</span>.Â  The MIC values obtained should be interpreted according to the criteria provided in Table l.</p>
<table><tbody class="Headless">
<tr class="First"><td class="Botrule Lrule Rrule Toprule" align="center" colspan="10" valign="middle"><p class="First"><span class="Bold"><span class="Emphasis">T</span></span><span class="Bold"><span class="Emphasis">a</span></span><span class="Bold"><span class="Emphasis">ble 1:Â  Susceptibility Test Interpretive Criteria for Doxycycline and Tetracycline</span></span></p></td></tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="bottom">
<p class="First">Â </p>
<p><span class="Bold"><span class="Emphasis">B</span></span><span class="Bold"><span class="Emphasis">a</span></span><span class="Bold"><span class="Emphasis">cteria</span></span><span class="Sup">a</span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" colspan="3" valign="bottom">
<p class="First"><span class="Bold"><span class="Emphasis">M</span></span><span class="Bold"><span class="Emphasis">inimal</span></span></p>
<p><span class="Bold"><span class="Emphasis">I</span></span><span class="Bold"><span class="Emphasis">nhibitory Concentration (mcg/mL)</span></span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" colspan="3" valign="bottom">
<p class="First">Â </p>
<p><span class="Bold"><span class="Emphasis">Z</span></span><span class="Bold"><span class="Emphasis">o</span></span><span class="Bold"><span class="Emphasis">ne Diameter (mm)</span></span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" colspan="3" valign="bottom">
<p class="First">Â </p>
<p><span class="Bold"><span class="Emphasis">Agar Dilution (mcg/mL)</span></span></p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">Â </p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First"><span class="Bold"><span class="Emphasis">S</span></span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First"><span class="Bold"><span class="Emphasis">I</span></span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First"><span class="Bold"><span class="Emphasis">R</span></span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First"><span class="Bold"><span class="Emphasis">S</span></span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First"><span class="Bold"><span class="Emphasis">I</span></span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First"><span class="Bold"><span class="Emphasis">R</span></span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First"><span class="Bold"><span class="Emphasis">S</span></span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First"><span class="Bold"><span class="Emphasis">I</span></span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First"><span class="Bold"><span class="Emphasis">R</span></span></p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Acinetobacter spp.</span></span></p>
<p>Â Â Â  Doxycycline</p>
<p>Â Â Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 4</p>
<p>â‰¤ 4</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>8</p>
<p>8</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 16</p>
<p>â‰¥ 16</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 13</p>
<p>â‰¥ 15</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>10 to 12</p>
<p>12 to 14</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 9</p>
<p>â‰¤ 11</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First">Anaerobes</p>
<p>Â Â Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>Â  â‰¤ 4</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>8</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 16</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Ba</span></span><span class="Italics"><span class="Emphasis">cillus anthracis</span></span><span class="Sup">b</span></p>
<p>Â Â Â  Doxycycline</p>
<p>Â Â Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 1</p>
<p>â‰¤ 1</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">B</span></span><span class="Italics"><span class="Emphasis">r</span></span><span class="Italics"><span class="Emphasis">u</span></span><span class="Italics"><span class="Emphasis">cella </span></span>species<span class="Sup">b</span></p>
<p>Â Â Â  Doxycycline</p>
<p>Â Â Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 1</p>
<p>â‰¤ 1</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">En</span></span><span class="Italics"><span class="Emphasis">terobacteriaceae</span></span></p>
<p>Â Â Â  Doxycycline</p>
<p>Â Â Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 4</p>
<p>â‰¤ 4</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>8</p>
<p>8</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 16</p>
<p>â‰¥ 16</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 14</p>
<p>â‰¥ 15</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>11 to 13</p>
<p>12 to 14</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 10</p>
<p>â‰¤ 11</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">F</span></span><span class="Italics"><span class="Emphasis">r</span></span><span class="Italics"><span class="Emphasis">an</span></span><span class="Italics"><span class="Emphasis">ciscella tularensis</span></span><span class="Sup">b</span></p>
<p>Â Â Â  Doxycycline</p>
<p>Â Â Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 4</p>
<p>â‰¤ 4</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Haemophilus influenzae</span></span></p>
<p>Â Â Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 2</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>4</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 8</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 29</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>26 to 28</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 25</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Mycoplasma pneumoniae</span></span><span class="Sup">b</span></p>
<p>Â Â Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 2</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">N</span></span><span class="Italics"><span class="Emphasis">eisseria gonorrhoeae</span></span><span class="Sup">c</span></p>
<p>Â Â Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 38</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>31 to 37</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 30</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 0.25</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>0.5 to 1</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 2</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">N</span></span><span class="Italics"><span class="Emphasis">o</span></span><span class="Italics"><span class="Emphasis">cardiae </span></span>and other aerobic</p>
<p><span class="Italics"><span class="Emphasis">A</span></span><span class="Italics"><span class="Emphasis">ctinomyces species</span></span></p>
<p>Â Â Â  Doxycycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 1</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>2 to 4</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 8</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">S</span></span><span class="Italics"><span class="Emphasis">treptococcus pneumoniae</span></span></p>
<p>Â Â Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 2</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>4</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 8</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 23</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>19 to 22</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 18</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">V</span></span><span class="Italics"><span class="Emphasis">ibrio cholerae</span></span></p>
<p>Â Â Â  Doxycycline</p>
<p>Â Â Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 4</p>
<p>â‰¤ 4</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>8</p>
<p>8</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 16</p>
<p>â‰¥ 16</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Yersinia pestis</span></span></p>
<p>Â Â Â  Doxycycline</p>
<p>Â Â Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 4</p>
<p>â‰¤ 4</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>8</p>
<p>8</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 16</p>
<p>â‰¥ 16</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Ureaplasma urealyticum</span></span></p>
<p>Â Â Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¤ 1</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 2</p>
</td>
</tr>
<tr class="Last"><td class="Botrule Lrule Rrule Toprule" colspan="10" valign="top">
<p class="First"><span class="Sup">aÂ  </span>Organisms susceptible to tetracycline are also considered susceptible to doxycycline. However, some</p>
<p>organisms that are intermediate or resistant to tetracycline may be susceptible to doxycycline.</p>
<p><span class="Sup">b </span>Â The current absence of resistance isolates precludes defining any results other than â€œSusceptibleâ€?.Â  If isolates yielding MIC results other than susceptible, they should be submitted to a reference laboratory for further testing.</p>
<p><span class="Sup">c</span>Â  Gonococci with 30 mcg tetracycline disk zone diameters of &lt; 19 mm usually indicate a plasmidÂ­mediated tetracycline resistant <span class="Italics"><span class="Emphasis">Neisseria gonorrhoeae </span></span>isolate.Â  Resistance in these <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> should be confirmed by a dilution test (MIC â‰¥ 16 mcg/mL).</p>
</td></tr>
</tbody></table>
<p>A report of <span class="Italics"><span class="Emphasis">Susceptible </span></span>(S) indicates that antimicrobial is likely to inhibit growth of the pathogen if the antimicrobial compound reaches the concentrations at the <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> site necessary to inhibit growth of the pathogen.Â  A report of <span class="Italics"><span class="Emphasis">Intermediate </span></span>(I) indicates that the result should be considered equivocal, and, if the bacteria is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. This category implies possible clinical applicability in body sites where the drug product is physiologically concentrated or in situations where high dosage of drug can be used. This category also provides a buffer zone that prevents small uncontrolled technical factors from causing major discrepancies interpretation.Â  A report of <span class="Italics"><span class="Emphasis">Resistant </span></span>(R) indicates that the pathogen is not likely to inhibit growth of the pathogen if the antimicrobial compound reaches the concentrations usually achievable at the <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> site: other therapy should be selected. </p>
<p><span class="Bold"><span class="Emphasis"><span class="Italics">Quality Control</span></span></span></p>
<p>Standardized susceptibility test procedures require the use of laboratory controls to monitor and ensure the accuracy and precision of supplies and reagents used in the assay, and the techniques of the individuals performing the test<span class="Sup">1,2,3,4,5,6,7</span>. Â Standard doxycycline and tetracycline powders should provide the following range of MIC values noted in Table 2.Â  For the diffusion technique using the 30 mcg doxycycline disk the criteria in Table 2 should be achieved.</p>
<table><tbody class="Headless">
<tr class="First"><td class="Botrule Lrule Rrule Toprule" align="center" colspan="4" valign="middle"><p class="First"><span class="Bold"><span class="Emphasis">T</span></span><span class="Bold"><span class="Emphasis">able 2: Acceptable Quality Control Ranges for Susceptibility Testing for Doxycycline and Tetracycline</span></span></p></td></tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="bottom">
<p class="First">Â </p>
<p><span class="Bold"><span class="Emphasis">QC <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">Strain</span></span></span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First"><span class="Bold"><span class="Emphasis">M</span></span><span class="Bold"><span class="Emphasis">inimal</span></span></p>
<p><span class="Bold"><span class="Emphasis">Inhibitory</span></span>Â <span class="Bold"><span class="Emphasis">Concentration</span></span></p>
<p><span class="Bold"><span class="Emphasis">(</span></span><span class="Bold"><span class="Emphasis">m</span></span><span class="Bold"><span class="Emphasis">c</span></span><span class="Bold"><span class="Emphasis">g/mL)</span></span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First"><span class="Bold"><span class="Emphasis">Z</span></span><span class="Bold"><span class="Emphasis">one Diameter (mm)</span></span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First"><span class="Bold"><span class="Emphasis">Agar Dilution (mcg/mL)</span></span></p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Enterococcus faecalis ATCC 29212</span></span></p>
<p>Â  Doxycycline</p>
<p>Â </p>
<p>Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>2 to 8</p>
<p>Â </p>
<p>Â 8 to 32</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>Â </p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Escherichia coli ATCC 25922</span></span></p>
<p>Â  Doxycycline</p>
<p>Â </p>
<p>Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>0.5 to 2</p>
<p>Â </p>
<p>0.5 to 2</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>18 to 24</p>
<p>Â </p>
<p>18 to 25</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>Â </p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Haemophilus influenzae ATCC 49247</span></span></p>
<p>Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>Â 4 to 32</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>14 to 22</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">N</span></span><span class="Italics"><span class="Emphasis">e</span></span><span class="Italics"><span class="Emphasis">isseria gonorrhoeae ATCC 49226</span></span></p>
<p>Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>30 to 42</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>0.25 to 1</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Staphylococcus aureus ATCC 25923</span></span></p>
<p>Â  Doxycycline</p>
<p>Â </p>
<p>Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">-</p>
<p>Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>23 to 29</p>
<p>Â </p>
<p>24 to 30</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>Â </p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Staphylococcus aureus ATCC 29213</span></span></p>
<p>Â  Doxycycline</p>
<p>Â </p>
<p>Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>0.12 to 0.5</p>
<p>Â </p>
<p>0.12 to 1</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>Â </p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Streptococcus pneumoniae ATCC 49619</span></span></p>
<p>Â  Doxycycline</p>
<p>Â </p>
<p>Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>0.015 to 0.12</p>
<p>Â </p>
<p>0.06 to 0.5</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>25 to 34</p>
<p>Â </p>
<p>27 to 31</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
<p>Â </p>
<p>-</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Bacteroides fragilis ATCC 25285</span></span></p>
<p>Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First">-</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>0.125 to 0.5</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Bacteroides thetaiotaomicron ATCC 29741</span></span></p>
<p>Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>8 to 32</p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Myc</span></span><span class="Italics"><span class="Emphasis">oplasma pneumoniae </span></span>ATCC 29342</p>
<p>Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>0.06 to 0.5</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>0.06 to 0.5</p>
</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Italics"><span class="Emphasis">Ureaplasma urealyticum </span></span>ATCC 33175</p>
<p>Â  Tetracycline</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>Â -</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>-</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">Â </p>
<p>â‰¥ 8</p>
</td>
</tr>
</tbody></table>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="cc4c99df-6bda-486b-993d-76e485726a1b"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">To reduce the development of drug-resistant bacteria and maintain the effectiveness of Doxycycline for Injection, USP and other antibacterial drugs, Doxycycline for Injection, USP should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by susceptible bacteria.Â  When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.Â  In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.</p>
<p>Doxycycline for Injection, USP is indicated in <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by the following microorganisms:</p>
<ul>
<li>Rickettsiae (Rocky Mountain spotted <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, typhus <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, and the typhus group, Q <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, rickettsial pox and tick <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fevers</span>).</li>
<li>
<span class="Italics"><span class="Emphasis">Mycoplasma pneumoniae</span></span> (PPLO, Eaton Agent).</li>
<li>Agents of psittacosis and ornithosis.</li>
<li>Agents of lymphogranuloma venereum and <span class="product-label-link" type="condition" conceptid="199726" conceptname="Granuloma inguinale">granuloma inguinale</span>.</li>
<li>The spirochetal agent of <span class="product-label-link" type="condition" conceptid="440637" conceptname="Relapsing fever">relapsing fever</span> (<span class="Italics"><span class="Emphasis">Borelia recurrentis</span></span>).</li>
</ul>
<p>The following gram-negative microorganisms:</p>
<ul>
<li>
<span class="Italics"><span class="Emphasis">Haemophilus ducreyi </span></span>(<span class="product-label-link" type="condition" conceptid="138973" conceptname="Chancroid">chancroid</span>).</li>
<li>
<span class="Italics"><span class="Emphasis">Yersinia pestis </span></span>(formerly <span class="Italics"><span class="Emphasis">Pasteurella pestis</span></span>) and <span class="Italics"><span class="Emphasis">Francisella tularensis </span></span>(formerly <span class="Italics"><span class="Emphasis">Pasturella tularensis</span></span>).</li>
<li>
<span class="Italics"><span class="Emphasis">Bartonella bacilliformis</span></span>.</li>
<li>
<span class="Italics"><span class="Emphasis">Bacteroides</span></span> species.</li>
<li>
<span class="Italics"><span class="Emphasis">Vibrio cholerae </span></span>(formerly<span class="Italics"><span class="Emphasis"> Vibrio comma</span></span>) and <span class="Italics"><span class="Emphasis">Campylobacter fetus </span></span>(formerly<span class="Italics"><span class="Emphasis"> Vibrio fetus)</span></span>.</li>
<li>
<span class="Italics"><span class="Emphasis">Brucella</span></span> species (in conjunction with streptomycin).</li>
</ul>
<p>Because many <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of the following groups of microorganisms have been shown to be resistant to tetracyclines, culture and susceptibility testing are recommended.</p>
<p>Doxycycline is indicated for treatment of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by the following gram-negative microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug:</p>
<ul>
<li>
<span class="Italics"><span class="Emphasis">Escherichia coli</span></span>.</li>
<li>
<span class="Italics"><span class="Emphasis">Enterobacter aerogenes</span></span> (formerly <span class="Italics"><span class="Emphasis">Aerobacter aerogenes</span></span>).</li>
<li>
<span class="Italics"><span class="Emphasis">Shigella</span></span> species.</li>
<li>
<span class="Italics"><span class="Emphasis">Acinetobacter </span></span>species (formerly <span class="Italics"><span class="Emphasis">Mima</span></span> species and <span class="Italics"><span class="Emphasis">Herellea</span></span> species).</li>
<li>
<span class="Italics"><span class="Emphasis">Haemophilus influenzae</span></span> (<span class="product-label-link" type="condition" conceptid="4170143" conceptname="Respiratory tract infection">respiratory infections</span>).</li>
<li>
<span class="Italics"><span class="Emphasis">Klebsiella</span></span> species (respiratory and <span class="product-label-link" type="condition" conceptid="4056621" conceptname="Recurrent urinary tract infection">urinary infections</span>).</li>
</ul>
<p>Doxycycline is indicated for treatment of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug:</p>
<ul>
<li><span class="product-label-link" type="condition" conceptid="438960" conceptname="Anthrax">Anthrax</span> due to <span class="Italics"><span class="Emphasis">Bacillus anthracis</span></span>, including inhalational <span class="product-label-link" type="condition" conceptid="438960" conceptname="Anthrax">anthrax</span> (post-exposure): to reduce the incidence or progression of disease following exposure to aerosolized <span class="Italics"><span class="Emphasis">Bacillus anthracis</span></span>.</li>
<li>
<span class="Italics"><span class="Emphasis">Streptococcus</span></span> species:</li>
</ul>
<p>Up to 44% of <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of <span class="Italics"><span class="Emphasis">Streptococcus pyogenes</span></span> and 74% of <span class="Italics"><span class="Emphasis">Enterococcus faecalis </span></span>(formerly<span class="Italics"><span class="Emphasis"> Streptococcus faecalis</span></span>) have been found to be resistant to tetracycline drugs.Â  Therefore, tetracyclines should not be used for streptococcal disease unless the organism has been demonstrated to be sensitive.</p>
<p>For <span class="product-label-link" type="condition" conceptid="4181583" conceptname="Upper respiratory infection">upper respiratory infections</span> due to group A beta-hemolytic streptococci, penicillin is the usual drug of choice, including prophylaxis of <span class="product-label-link" type="condition" conceptid="442313" conceptname="Rheumatic fever">rheumatic fever</span>.</p>
<ul>
<li>
<span class="Italics"><span class="Emphasis">Streptococcus pneumoniae </span></span>(formerly<span class="Italics"><span class="Emphasis"> Diplococcus pneumoniae</span></span>).</li>
<li>
<span class="Italics"><span class="Emphasis">Staphylococcus aureus</span></span>, respiratory, skin and <span class="product-label-link" type="condition" conceptid="4320030" conceptname="Soft tissue infection">soft tissue infections</span>.Â  Tetracyclines are not the drugs of choice in the treatment of any type of <span class="product-label-link" type="condition" conceptid="435459" conceptname="Staphylococcal infectious disease">staphylococcal infections</span>.</li>
</ul>
<p>When penicillin is contraindicated, doxycycline is an alternative drug in the treatment of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> due to:</p>
<ul>
<li>
<span class="Italics"><span class="Emphasis">Neisseria gonorrhoeae</span></span> and <span class="Italics"><span class="Emphasis">N. meningitidis</span></span>.</li>
<li>
<span class="Italics"><span class="Emphasis">Treponema pallidum</span></span> and <span class="Italics"><span class="Emphasis">Treponema pertenue</span></span> (<span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span> and yaws).</li>
<li>
<span class="Italics"><span class="Emphasis">Listeria monocytogenes</span></span>.</li>
<li>
<span class="Italics"><span class="Emphasis">Clostridium</span></span> species.</li>
<li>
<span class="Italics"><span class="Emphasis">Fusobacterium fusiforme</span></span> (Vincentâ€™s <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>).</li>
<li>
<span class="Italics"><span class="Emphasis">Actinomyces</span></span> species.</li>
</ul>
<p>In acute intestinal <span class="product-label-link" type="condition" conceptid="438959" conceptname="Amebic infection">amebiasis</span>, doxycycline may be a useful adjunct to amebicides.</p>
<p>Doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="ccf235a4-c869-46bb-8316-9470e2996f68"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">This drug is contraindicated in persons who have shown <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the tetracyclines.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="aab527b0-50ba-4139-b06d-160c1ce17531"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">THE USE OF DRUGS OF THE TETRACYCLINE CLASS DURING TOOTH DEVELOPMENT (LAST HALF OF PREGNANCY, INFANCY AND CHILDHOOD TO THE AGE OF 8 YEARS) MAY CAUSE PERMANENT DISCOLORATION OF THE TEETH (YELLOW-GRAY-BROWN).Â  This adverse reaction is more common during long-term use of the drugs but has been observed following repeated short-term courses.Â  <span class="product-label-link" type="condition" conceptid="4131814" conceptname="Enamel hypoplasia">Enamel hypoplasia</span> has also been reported.Â  TETRACYCLINE DRUGS, THEREFORE, SHOULD NOT BE USED IN THIS AGE GROUP, EXCEPT FOR <span class="product-label-link" type="condition" conceptid="438960" conceptname="Anthrax">ANTHRAX</span>, INCLUDING INHALATIONAL <span class="product-label-link" type="condition" conceptid="438960" conceptname="Anthrax">ANTHRAX</span> (POST-EXPOSURE), UNLESS OTHER DRUGS ARE NOT LIKELY TO BE EFFECTIVE OR ARE CONTRAINDICATED.</p>
<p><span class="Italics"><span class="Emphasis">Clostridium difficile </span></span>associated <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> (CDAD) has been reported with use of nearly all antibacterial agents, including doxycycline for injection, USP, and may range in severity from mild <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> to fatal <span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span>. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of <span class="Italics"><span class="Emphasis">C. difficile.</span></span></p>
<p><span class="Italics"><span class="Emphasis">C. difficile </span></span>produces toxins A and B which contribute to the development of CDAD.Â  Hypertoxin producing <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of <span class="Italics"><span class="Emphasis">C. difficile </span></span>cause increased morbidity and mortality, as these <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> can be refractory to antimicrobial therapy and may require colectomy.Â  CDAD must be considered in all patients who present with <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> following antibiotic use. Â Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.</p>
<p>If CDAD is suspected or confirmed, ongoing antibiotic use not directed against <span class="Italics"><span class="Emphasis">C. difficile</span></span> may need to be discontinued. Â Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of <span class="Italics"><span class="Emphasis">C. difficile,</span></span> and surgical evaluation should be instituted as clinically indicated. </p>
<p><span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">Photosensitivity</span> manifested by an exaggerated sunburn reaction has been observed in some individuals taking tetracyclines.Â  Patients apt to be exposed to direct sunlight or ultraviolet light, should be advised that this reaction can occur with tetracycline drugs, and treatment should be discontinued at the first evidence of <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">skin erythema</span>.</p>
<p>The anti-anabolic action of the tetracyclines may cause an increase in BUN.Â  Studies to date indicate that this does not occur with the use of doxycycline in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>.</p>
<p><span class="Italics"><span class="Emphasis"><span class="Bold">Usage in Pregnancy</span></span></span></p>
<p>(See above <span class="Bold"><span class="Emphasis"><a href="#aab527b0-50ba-4139-b06d-160c1ce17531">WARNINGS</a></span></span> about use during tooth development).</p>
<p>Doxycycline for injection has not been studied in pregnant patients.Â  It should not be used in pregnant women unless, in the judgment of the physician, it is essential for the welfare of the patient.</p>
<p>Results of animal studies indicate that tetracyclines cross the placenta, are found in fetal tissues and can have toxic effects on the developing fetus (often related to retardation of skeletal development).Â  Evidence of embryotoxicity has also been noted in animals treated early in pregnancy.</p>
<p><span class="Italics"><span class="Emphasis"><span class="Bold">Usage in Children</span></span></span></p>
<p>The use of doxycycline for injection in children under 8 years is not recommended because safe conditions for its use have not been established.Â  (See above <span class="Bold"><span class="Emphasis"><a href="#aab527b0-50ba-4139-b06d-160c1ce17531">WARNINGS</a></span></span> about use during tooth development).</p>
<p>As with other tetracyclines, doxycycline forms a stable calcium complex in any bone-forming tissue.Â  A decrease in the fibula growth rate has been observed in prematures given oral tetracycline in doses of 25 mg/kg every six hours.Â  This reaction was shown to be reversible when the drug was discontinued.</p>
<p>Tetracyclines are present in the milk of lactating women who are taking a drug in this class.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="efdf322c-8a50-4128-8c63-fc08ce4d8238"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">Prescribing doxycycline in the absence of a proven or strongly suspected <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span> or a <span class="product-label-link" type="condition" conceptid="4118659" conceptname="Prophylactic">prophylactic</span> indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.</p>
<p>As with other antibiotic preparations, use of this drug may result in overgrowth of nonsusceptible organisms, including fungi.Â  If <span class="product-label-link" type="condition" conceptid="4105019" conceptname="Superimposed infection">superinfection</span> occurs, the antibiotic should be discontinued and appropriate therapy instituted.</p>
<p>In venereal diseases when coexistent <span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span> is suspected, a dark field examination should be done before treatment is started and the blood serology repeated monthly for at least four months.</p>
<p>Because tetracyclines have been shown to depress plasma <span class="product-label-link" type="condition" conceptid="4173906" conceptname="Clotting factor II assay">prothrombin</span> activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage.</p>
<p>In long-term therapy, periodic laboratory evaluation of organ systems, including hematopoietic, renal and hepatic studies should be performed.</p>
<p>All <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> due to group A beta-hemolytic streptococci should be treated for at least 10 days.</p>
<p>Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline in conjunction with penicillin.</p>
<div class="Section" data-sectionCode="42232-9">
<a name="a8c08324-8922-4298-a003-d810c08a06eb"></a><a name="section-7.1"></a><p></p>
<h2>Pregnancy</h2>
<p class="First"><span class="Bold"><span class="Emphasis"><span class="Italics">Teratogenic Effects: Pregnancy Category D</span></span></span></p>
<p>There are no adequate and well-controlled studies on the use of doxycycline in pregnant women.Â  The vast majority of reported experience with doxycycline during human pregnancy is short-term, first trimester exposure.Â  There are no human data available to assess the effects of long-term therapy of doxycycline in pregnant women such as that proposed for treatment of <span class="product-label-link" type="condition" conceptid="438960" conceptname="Anthrax">anthrax</span> exposure.Â  An expert review of published data on experiences with doxycycline use during pregnancy by TERISâ€“the Teratogen Information Systemâ€“concluded that therapeutic doses during pregnancy are unlikely to pose a substantial teratogenic risk (the quantity and quality of data were assessed as limited to fair), but the data are insufficient to state that there is no risk.<span class="Sup">1 </span></p>
<p>A case-control study (18,515 mothers of infants with congenital anomalies and 32,804 mothers of infants with no congenital anomalies) shows a weak but marginally statistically significant association with total malformations and use of doxycycline anytime during pregnancy.Â  (Sixty-three (0.19%) of the controls and 56 (0.3%) of the cases were treated with doxycycline).Â  This association was not seen when the analysis was confined to maternal treatment during the period of organogenesis (i.e., in the second and third months of gestation) with the exception of a marginal relationship with <span class="product-label-link" type="condition" conceptid="4102400" conceptname="Neural tube defect">neural tube defect</span> based on only two exposed cases.<span class="Sup">2 </span></p>
<p>A small prospective study of 81 pregnancies describes 43 pregnant women treated for 10 days with doxycycline during early first trimester.Â  All mothers reported their exposed infants were normal at 1 year of age.<span class="Sup">3</span></p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="e108abec-8382-429e-990c-104ce87d6404"></a><a name="section-7.2"></a><p></p>
<h2>Nursing Mothers<br>
</h2>
<p class="First">Tetracyclines are excreted in human milk, however, the extent of absorption of tetracyclines, including doxycycline, by the breastfed infant is not known.Â  Short-term use by lactating women is not necessarily contraindicated; however, the effects of prolonged exposure to doxycycline in breast milk are unknown.<span class="Sup">4</span>Â  Because of the potential for adverse reactions in nursing infants from doxycycline, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother (see <span class="Bold"><span class="Emphasis"><a href="#aab527b0-50ba-4139-b06d-160c1ce17531">WARNINGS</a></span></span>).</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="e05b2252-3402-4885-b502-0573802dd3a8"></a><a name="section-7.3"></a><p></p>
<h2>Information for Patients<br>
</h2>
<p class="First">Patients should be counseled that antibacterial drugs including doxycycline should only be used to treat <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infections</span>.Â  They do not treat <span class="product-label-link" type="condition" conceptid="440029" conceptname="Viral disease">viral infections</span> (e.g., the <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">common cold</span>).Â  When doxycycline is prescribed to treat a <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span>, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed.Â  Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by doxycycline or other antibacterial drugs in the future.</p>
<p><span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span> is a common problem caused by antibiotics which usually ends when the antibiotic is discontinued. Â Sometimes after starting treatment with antibiotics, patients can develop watery and <span class="product-label-link" type="condition" conceptid="443530" conceptname="Hematochezia">bloody stools</span> (with or without <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">stomach cramps</span> and <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>) even as late as two or more months after having taken the last dose of the antibiotic. Â If this occurs, patients should contact their physician as soon as possible.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="ff6198c8-6f5a-4317-9205-f9395f747f9f"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<div class="Section" data-sectionCode="34084-4">
<a name="b23ce524-1450-407b-bbd2-b671c5b974ff"></a><a name="section-8.1"></a><p></p>
<h2>Gastrointestinal</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">Anorexia</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="436147" conceptname="Glossitis">glossitis</span>, <span class="product-label-link" type="condition" conceptid="31317" conceptname="Dysphagia">dysphagia</span>, <span class="product-label-link" type="condition" conceptid="4184503" conceptname="Enterocolitis">enterocolitis</span> and inflammatory lesions (with monilial overgrowth) in the anogenital region.Â  Hepatotoxicity has been reported rarely.Â  These reactions have been caused by both the oral and parenteral administration of tetracyclines.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="f36d13e8-fd90-43f7-a204-aa5d19be8080"></a><a name="section-8.2"></a><p></p>
<h2>Skin</h2>
<p class="First">Maculopapular and erythematous <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rashes</span>.Â  <span class="product-label-link" type="condition" conceptid="4270887" conceptname="Erythroderma">Exfoliative dermatitis</span> has been reported but is uncommon.Â  <span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">Photosensitivity</span> is discussed above (see <span class="Bold"><span class="Emphasis"><a href="#aab527b0-50ba-4139-b06d-160c1ce17531">WARNINGS</a></span></span>).</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="d41d9356-ea34-44fd-9804-a02b56aefecc"></a><a name="section-8.3"></a><p></p>
<h2>Renal Toxicity<br>
</h2>
<p class="First">Rise in BUN has been reported and is apparently dose related (see <span class="Bold"><span class="Emphasis"><a href="#aab527b0-50ba-4139-b06d-160c1ce17531">WARNINGS</a></span></span>).</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="d2bdae64-7cae-4a27-821a-9d4bc8ee3d0d"></a><a name="section-8.4"></a><p></p>
<h2><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity Reactions</span><br>
</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">Urticaria</span>, <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioneurotic edema</span>, <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>, <span class="product-label-link" type="condition" conceptid="4101602" conceptname="Henoch-Schonlein purpura">anaphylactoid purpura</span>, <span class="product-label-link" type="condition" conceptid="4138837" conceptname="Pericarditis">pericarditis</span> and exacerbation of <span class="product-label-link" type="condition" conceptid="257628" conceptname="Systemic lupus erythematosus">systemic lupus erythematosus</span>.</p>
<p>Bulging fontanels in infants and <span class="product-label-link" type="condition" conceptid="312902" conceptname="Benign intracranial hypertension">benign intracranial hypertension</span> in adults have been reported in individuals receiving full therapeutic dosages.Â  These conditions disappeared rapidly when the drug was discontinued.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="b44ac783-92ff-41fa-846a-ce757881c489"></a><a name="section-8.5"></a><p></p>
<h2>Blood</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">Hemolytic anemia</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, <span class="product-label-link" type="condition" conceptid="320073" conceptname="Neutropenia">neutropenia</span> and <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">eosinophilia</span> have been reported.</p>
<p>When given over <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span>, tetracyclines have been reported to produce brown-black microscopic discoloration of thyroid glands.Â  No abnormalities of thyroid function studies are known to occur.</p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="d5347e6d-0689-4cdb-b17a-8542397d6ceb"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First"><span class="Bold"><span class="Emphasis">NOTE:</span></span>Â  Rapid administration is to be avoided.Â  Parenteral therapy is indicated only when oral therapy is not indicated.Â  Oral therapy should be instituted as soon as possible.Â  If intravenous therapy is given over <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span> of time, <span class="product-label-link" type="condition" conceptid="320741" conceptname="Thrombophlebitis">thrombophlebitis</span> may result.</p>
<p>THE USUAL DOSAGE AND FREQUENCY OF ADMINISTRATION OF DOXYCYCLINE FOR INJECTION (100 to 200 MG/DAY) DIFFERS FROM THAT OF THE OTHER TETRACYCLINES (1 to 2 G/DAY).Â  EXCEEDING THE RECOMMENDED DOSAGE MAY RESULT IN AN INCREASED INCIDENCE OF SIDE EFFECTS.</p>
<p>Studies to date have indicated that doxycycline hyclate at the usual recommended doses does not lead to excessive accumulation of the antibiotic in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span>.</p>
<div class="Section" data-sectionCode="34068-7">
<a name="db41eefa-df93-4b3d-ae15-2158dd89176d"></a><a name="section-9.1"></a><p></p>
<h2>Adults</h2>
<p class="First">The usual dosage of doxycycline for injection is 200 mg on the first day of treatment administered in one or two infusions.Â  Subsequent daily dosage is 100 to 200 mg depending upon the severity of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>, with 200 mg administered in one or two infusions.</p>
<p>In the treatment of primary and <span class="product-label-link" type="condition" conceptid="437787" conceptname="Secondary syphilis">secondary syphilis</span>, the recommended dosage is 300 mg daily for at least 10 days.</p>
<p>In the treatment of inhalational <span class="product-label-link" type="condition" conceptid="438960" conceptname="Anthrax">anthrax</span> (post-exposure) the recommended dose is 100 mg of doxycycline, twice a day.Â  Parenteral therapy is only indicated when oral therapy is not indicated and should not be continued over a prolonged period of time.Â  Oral therapy should be instituted as soon as possible.Â  Therapy must continue for a total of 60 days.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="a81dd685-3ca2-41ce-aacc-458bbafc21d4"></a><a name="section-9.2"></a><p></p>
<h2>For Children Above Eight Years of Age<br>
</h2>
<p class="First">The recommended dosage schedule for children weighing 100 pounds or less is 2 mg/lb of body weight on the first day of treatment, administered in one or two infusions.Â  Subsequent daily dosage is 1 to 2 mg/lb of body weight given as one or two infusions, depending on the severity of the <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>.Â  For children over 100 pounds the usual adult dose should be used (see <span class="Bold"><span class="Emphasis"><span class="Italics"><a href="#aab527b0-50ba-4139-b06d-160c1ce17531">WARNINGS, Usage in Children</a></span></span></span>).</p>
<p>In the treatment of inhalational <span class="product-label-link" type="condition" conceptid="438960" conceptname="Anthrax">anthrax</span> (post-exposure) the recommended dose is 1 mg/lb (2.2 mg/kg) of body weight, twice a day in children weighing less than 100 lb (45 kg).Â  Parenteral therapy is only indicated when oral therapy is not indicated and should not be continued over a prolonged period of time.Â  Oral therapy should be instituted as soon as possible.Â  Therapy must continue for a total of 60 days.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="eb816b4c-418c-4d86-a47d-5182e54fe0cd"></a><a name="section-9.3"></a><p></p>
<h2>General</h2>
<p class="First">The duration of infusion may vary with the dose (100 to 200 mg/day), but is usually one to four hours.Â  A recommended minimum infusion time for 100 mg of a 0.5 mg/mL solution is one hour.Â  Therapy should be continued for at least 24 to 48 hours after symptoms and <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> have subsided.Â  The therapeutic antibacterial serum activity will usually persist for 24 hours following recommended dosage.</p>
<p>Intravenous solutions should not be injected intramuscularly or subcutaneously.Â  Caution should be taken to avoid the inadvertent introduction of the intravenous solution into the adjacent soft tissue.</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="f7df2a16-7a5a-4b4b-8117-2f0c93d36b48"></a><a name="section-10"></a><p></p>
<h1>PREPARATION OF SOLUTION<br>
</h1>
<p class="First">To prepare a solution containing 10 mg/mL, the contents of the vial should be reconstituted with 10 mL (for the 100 mg/vial container) or 20 mL (for the 200 mg/vial container) of Sterile Water for Injection or any of the 10 intravenous infusion solutions listed below.Â  Each 100 mg of doxycycline for injection (i.e., withdraw entire solution from the 100 mg vial) is further diluted with 100 mL to 1,000 mL of the intravenous solutions listed below.Â  Each 200 mg of Doxycycline for Injection (i.e., withdraw entire solution from the 200 mg vial) is further diluted with 200 mL to 2,000 mL of the following intravenous solutions:</p>
<ol>
<li>Sodium Chloride Injection, USP</li>
<li>5% Dextrose Injection, USP</li>
<li>Ringerâ€™s Injection, USP</li>
<li>Invert Sugar, 10% in Water</li>
<li>Lactated Ringerâ€™s Injection, USP</li>
<li>Dextrose 5% in Lactated Ringerâ€™s</li>
<li>Normosol-M<span class="Sup">Â®</span> in D5-W (Abbott)</li>
<li>Normosol-R<span class="Sup">Â®</span> in D5-W (Abbott)</li>
<li>Plasma-Lyte<span class="Sup">Â®</span> 56 in 5% Dextrose (Baxter)</li>
<li>Plasma-Lyte<span class="Sup">Â®</span> 148 in 5% Dextrose (Baxter)</li>
</ol>
<p>This will result in desired concentrations of 0.1 to 1 mg/mL.Â  Concentrations lower than 0.1 mg/mL or higher than 1 mg/mL are not recommended.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="d1df9cc3-8b1b-4a7f-9231-d899ffd74d8b"></a><a name="section-10.1"></a><p></p>
<h2>Stability</h2>
<p class="First">Doxycycline is stable for 48 hours in solution when diluted with Sodium Chloride Injection, USP, or 5% Dextrose Injection, USP, to concentrations between 1 mg/mL and 0.1 mg/mL and stored at 25Â°C.Â  Doxycycline in these solutions is stable under fluorescent light for 48 hours, but must be protected from direct sunlight during storage and infusion.Â  Reconstituted solutions (1 to 0.1 mg/mL) may be stored up to 72 hours prior to start of infusion if refrigerated and protected from sunlight and artificial light.Â  Infusion must then be completed within 12 hours.Â  Solutions must be used within these time periods or discarded.</p>
<p>Doxycycline, when diluted with Ringerâ€™s Injection, USP, or Invert Sugar, 10% in Water, to a concentration between 1 mg/mL and 0.1 mg/mL, must be completely infused within 12 hours after reconstitution to ensure adequate stability.Â  During infusion, the solution must be protected from direct sunlight. Reconstituted solutions (1 to 0.1 mg/mL) may be stored up to 72 hours prior to start of infusion if refrigerated and protected from sunlight and artificial light.Â  Infusion must then be completed within 12 hours.Â  Solutions must be used within these time periods or discarded.</p>
<p>Diluted solutions (0.1 to 1 mg/mL) prepared using Normosol-M<span class="Sup">Â®</span> in D5-W (Abbott); Normosol-R<span class="Sup">Â®</span> in D5-W (Abbott); Plasma-Lyte<span class="Sup">Â®</span> 56 in 5% Dextrose (Baxter); or Plasma-Lyte<span class="Sup">Â®</span> 148 in 5% Dextrose (Baxter) may also be stored up to 12 hours prior to start of infusion, if refrigerated and protected from sunlight and artificial light.Â  The infusion must be completed within 12 hours.Â  Solutions must be used within these time periods or discarded.</p>
<p>When diluted with Lactated Ringerâ€™s Injection, USP, or Dextrose 5% in Lactated Ringerâ€™s, infusion of the solution (ca. 1 mg/mL) or lower concentrations (not less than 0.1 mg/mL) must be completed within six hours after reconstitution to ensure adequate stability.Â  During infusion, the solution must be protected from direct sunlight. Solutions must be used within this time period or discarded.</p>
<p>Solutions of doxycycline for injection, at a concentration of 10 mg/mL in Sterile Water for Injection, when frozen immediately after reconstitution are stable for eight weeks when stored at â€“20Â°C.Â  If the product is warmed, care should be taken to avoid heating it after the thawing is complete.Â  Once thawed the solution should not be refrozen.</p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="dcc73c9a-ef13-4edc-bcf5-20071070fb08"></a><a name="section-11"></a><p></p>
<h1>HOW SUPPLIED</h1>
<table><tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Bold"><span class="Emphasis">Product</span></span></p>
<p><span class="Bold"><span class="Emphasis">No.</span></span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Bold"><span class="Emphasis">NDCÂ Â Â Â Â Â Â  </span></span></p>
<p><span class="Bold"><span class="Emphasis">No.</span></span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><br></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">1311Â Â Â Â Â Â Â Â Â  </p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">63323-130-11Â Â Â  </p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">Doxycycline for Injection, USP (equivalent to <span class="Bold"><span class="Emphasis">100 mg Doxycycline</span></span> with 480 mg ascorbic acid and 300 mg mannitol per vial), lyophilized in a flip-top vial, in packages of 10.</p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">16420</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First">63323-164-20Â Â Â  </p>
<p>Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â  </p>
</td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">Doxycycline for Injection, USP (equivalent to <span class="Bold"><span class="Emphasis">200 mg Doxycycline</span></span> with 960 mg ascorbic acid and 600 mg mannitol per vial), lyophilized in a flip-top vial, packaged individually.</p></td>
</tr>
</tbody></table>
<p class="First">Store at 20Â° to 25Â°C (68Â° to 77Â°F) [see USP Controlled Room Temperature].</p>
<p><span class="Bold"><span class="Emphasis">PROTECT FROM LIGHT.</span></span></p>
<p>Retain in carton until time of use.</p>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="dd218061-7932-4ffc-bd3e-faca0eeb3879"></a><a name="section-12"></a><p></p>
<h1>REFERENCES</h1>
<ol>
<li>Clinical and Laboratory Standards Institute (CLSI). <span class="Italics"><span class="Emphasis">Performance Standards for Antimicrobial Susceptibility Testing; Twenty-third Informational Supplement. </span></span>CLSI document M100-S23. Â Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087, USA, 2013.</li>
<li>Clinical and Laboratory Standards Institute. <span class="Italics"><span class="Emphasis">Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard </span></span>- <span class="Italics"><span class="Emphasis">9th ed. </span></span>CLSI document M07-A9, CLSI, Wayne, PA, 2012.</li>
<li>Clinical and Laboratory Standards Institute. <span class="Italics"><span class="Emphasis">Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard </span></span>-<span class="Italics"><span class="Emphasis">11th ed. </span></span>CLSI document M02-A11, CLSI, Wayne, PA, 2012.</li>
<li>Clinical and Laboratory Standards Institute. <span class="Italics"><span class="Emphasis">Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline - Second Edition. </span></span>CLSI document M45-A2. Â Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, 2010.</li>
<li>Clinical and Laboratory Standards Institute (CLSI). <span class="Italics"><span class="Emphasis">Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard </span></span>- <span class="Italics"><span class="Emphasis">Eighth Edition. </span></span>CLSI document M11-A8. Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, PA 19087 USA, 2012.</li>
<li>Clinical and Laboratory Standards Institute. <span class="Italics"><span class="Emphasis">Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard - Second Edition. </span></span>CLSI document M24-A2. Â Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, 2011.</li>
<li>Clinical and Laboratory Standards Institute<span class="Italics"><span class="Emphasis">. Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline. Â </span></span>CLSI document M43-A. Â Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, 2011.</li>
<li>Friedman JM and Polifka JE. <span class="Italics"><span class="Emphasis">Teratogenic Effects of Drugs. A Resource for Clinicians (TERIS)</span></span>. Baltimore, MD: The Johns Hopkins University Press: 2000; 149-195.</li>
<li>Cziezel AE and Rockenbauer M. Teratogenic study of doxycycline. <span class="Italics"><span class="Emphasis">Obstet Gynecol</span></span> 1997; 89: 524-528.</li>
<li>Horne HW Jr. and Kundsin RB. The role of mycoplasma among 81 consecutive pregnancies: a prospective study. <span class="Italics"><span class="Emphasis">Int J Fertil</span></span> 1980; 25:315-317.</li>
<li>Hale T. <span class="Italics"><span class="Emphasis">Medications and Mothers Milk</span></span>. 9th edition. Amarillo, TX: Pharmasoft Publishing 2000; 225-226.</li>
</ol>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="df2887c8-730b-45cb-b39c-4a6a10b084e3"></a><a name="section-13"></a><p></p>
<h1></h1>
<p class="First"><img alt="logo" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b0894010-39bd-459f-8563-cf83343105ee&amp;name=doxycycline-for-injection-usp-figure-2-fk-address.jpg">Â </p>
<p>45824G</p>
<p>Revised: February 2014</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="e310fef2-9fd2-4f46-a85b-fb5b38d9146b"></a><a name="section-14"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold"><span class="Emphasis">PACKAGE LABEL - PRINCIPAL DISPLAY - Doxycycline 100 mg Vial Label</span></span></p>
<p><span class="Bold"><span class="Emphasis">NDC</span></span> 63323-130-11</p>
<p>1311</p>
<p><span class="Bold"><span class="Emphasis">Doxy 100â„¢</span></span></p>
<p><span class="Bold"><span class="Emphasis">Doxycycline for Injection, USP</span></span></p>
<p>equivalent to </p>
<p><span class="Bold"><span class="Emphasis">100 mg per vialÂ  </span></span>Doxycycline</p>
<p>For IV Infusion Only.</p>
<p>Must Dilute Reconstituted Solution.</p>
<p>Rx only</p>
<p><img alt="1311-vial" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b0894010-39bd-459f-8563-cf83343105ee&amp;name=doxycycline-for-injection-usp-figure-3-vial-1311.jpg">Â </p>
<p>Â </p>
<p>Â </p>
<p><span class="Bold"><span class="Emphasis">PACKAGE LABEL - PRINCIPAL DISPLAY - Doxycycline 100 mg Tray Label</span></span></p>
<p><span class="Bold"><span class="Emphasis">NDC</span></span> 63323-130-11</p>
<p>1311</p>
<p><span class="Bold"><span class="Emphasis">Doxy 100â„¢</span></span></p>
<p><span class="Bold"><span class="Emphasis">Doxycycline for Injection, USP</span></span></p>
<p>equivalent to </p>
<p><span class="Bold"><span class="Emphasis">100 mg per vial Â </span></span>Doxycycline</p>
<p>For IV Infusion Only.</p>
<p>Must Dilute Reconstituted Solution.</p>
<p>Contents: 10 vials </p>
<p>Rx only </p>
<p><img alt="1311-tray" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b0894010-39bd-459f-8563-cf83343105ee&amp;name=doxycycline-for-injection-usp-figure-4-1311-tray.jpg">Â </p>
<p>Â </p>
<p>Â </p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DOXY 100Â 		
					</strong><br><span class="contentTableReg">doxycycline injection, powder, lyophilized, for solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:63323-130</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DOXYCYCLINE HYCLATE</strong> (DOXYCYCLINE ANHYDROUS) </td>
<td class="formItem">DOXYCYCLINE ANHYDROUS</td>
<td class="formItem">100Â mg Â inÂ 10Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ASCORBIC ACID</strong></td>
<td class="formItem">480Â mg Â inÂ 10Â mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MANNITOL</strong></td>
<td class="formItem">300Â mg Â inÂ 10Â mL</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:63323-130-11</td>
<td class="formItem">10  in 1 TRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">10 mL in 1 VIAL</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA062475</td>
<td class="formItem">10/17/2000</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Fresenius Kabi USA, LLC
							(608775388)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Fresenius Kabi USA, LLC</td>
<td class="formItem"></td>
<td class="formItem">023648251</td>
<td class="formItem">MANUFACTURE(63323-130)</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Fresenius Kabi USA, LLC</td>
<td class="formItem"></td>
<td class="formItem">840771732</td>
<td class="formItem">MANUFACTURE(63323-130)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 4/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>c3d6f8c4-e275-460a-911c-01038578d00d</div>
<div>Set id: b0894010-39bd-459f-8563-cf83343105ee</div>
<div>Version: 4</div>
<div>Effective Time: 20140415</div>
</div>
</div>Â <div class="DistributorName">Fresenius Kabi USA, LLC</div></p>
</body></html>
